SCHEMBL30107904

SCHEMBL30107904

c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)n3)cc(-n3c4ccc(-c5ccccc5)cc4c4cc(-c5ccccc5)ccc43)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.47
KMT2A Q03164 10/20 0.47
HPGD P15428 9/20 0.47
ALDH1A1 P00352 8/20 0.47
MAPT P10636 8/20 0.47
NTSR1 P30989 1/20 0.47
KDM4E B2RXH2 5/20 0.42
LMNA P02545 2/20 0.42
GLA P06280 1/20 0.42
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
NPSR1 Q6W5P4 2/20 0.40
RXFP1 Q9HBX9 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
MAPK1 P28482 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9888887 1.00 MEN1 (0.47) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL30107725 0.97 MEN1 (0.45) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL29327986 0.96 MEN1 (0.44) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL30107816 0.96 MEN1 (0.44) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL30107764 0.96 MEN1 (0.44) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL30107851 0.96 MEN1 (0.45) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL30107714 0.96 MEN1 (0.45) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL15887856 0.94 KMT2A (0.42) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL15887911 0.94 KMT2A (0.42) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL15887986 0.94 KMT2A (0.42) MEN1KMT2AHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542260-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542260-B2 Composition of matter for use in organic light-emitting diodes CRY2, NDUFV3, SLCO1B3 MEN1 3059/4885KMT2A 4205/4885HPGD 1849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.